About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 959 record(s)
Req # A-2022-001099
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108621-44, Breast Implant Registry Considerations - Update.Organization: Health Canada
July 2023
Req # A-2022-001215
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-109352-502.Organization: Health Canada
July 2023
Req # A-2022-001251
Adverse Drug Reactions (ADRs) for DEXILANT. Report numbers: 001021090, E2B_05841716, E2B_05864940, E2B_05850390. ADRs for ENTYVIO. Report numbers: 001017634, E2B_05863270. ADRs for ONDANSETRON. Report numbers: E2B_05864888, E2B_05825021,…Organization: Health Canada
July 2023
Req # A-2022-001411
Adverse Drug Reactions (ADRs). Report numbers: E2B_05843007, E2B_05858955, E2B_05901643, E2B_05912131, E2B_05932958, E2B_05958604.Organization: Health Canada
July 2023
Req # A-2022-001466
Adverse Drug Reactions (ADRs). Report numbers: E2B_05954104, E2B_05885170, E2B_05900714, E2B_05893696, 001016233, E2B_05941199, E2B_05933164, 001016353, E2B_05906789, E2B_05958442.Organization: Health Canada
July 2023
Req # A-2022-001601
Adverse Drug Reaction (ADR) for CAFFEINE CITRATE. Report number: E2B_05975194.Organization: Health Canada
July 2023
Req # A-2022-001602
Adverse Drug Reactions (ADRs). Report numbers: E2B_05999062, E2B_05970123, E2B_05998743, E2B_05984698, 001020501, E2B_06008302, E2B_05984446, E2B_06001031, E2B_06004067.Organization: Health Canada
July 2023
Req # A-2022-001604
Adverse Drug Reactions (ADRs). Report numbers: 001026185, 001022431, 001021230, E2B_05970570.Organization: Health Canada
July 2023
Req # A-2022-001614
Adverse Drug Reactions (ADRs). Report numbers: E2B_02641517, E2B_02675533, E2B_02791931, 000915904, E2B_02821447, E2B_02864513, 000922266, 000927627, 000934959, 000936174.Organization: Health Canada
July 2023
Req # A-2022-001619
Adverse Drug Reaction (ADR). Report number: 001026724.Organization: Health Canada
July 2023